Ypsomed sells pen needle and BGM business to MTD Medical Technology and Devices

Ypsomed AG sold its pen needle and blood glucose monitoring business to MTD Medical Technology and Devices S.p.A. The divestment allows Ypsomed to focus on its mylife Loop insulin pump solution.

“Ypsomed, a leading developer and manufacturer in the field of self-medication and diabetes care, has carved-out and sold its pen needle and blood glucose monitoring systems (BGMs) business to MTD.”8advisory.com

• 1 source
• 8advisory.comEight Advisory advised Ypsomed AG on the sale of its pen needle and blood glucose monitoring business to MTD Medical Technology and Devices - Eight AdvisoryEditeursApr 5, 2024

Summarized from public sources; check the original articles before acting on it.